Exactly and excellent post. $VCEL products are direct competitors to "old school" medical procedures such as knee replacements, heart transplants, skin grafts etc.
That .05 spread doesn't help (longs) either imo. In the long term though, if company performs, none of this will matter. Again just my opine, it's going to trade a range, with an up trend towards news to confirm sales traction in back half of 2017. That confirmation will fundamentally change the trading range.
News 
Market Data 
Discover 
AI
